Back
ESC Premium Access

Clinical effectiveness of new oral anticoagulants in US and Europe for stroke prevention in atrial fibrillation

Session: Poster session 2 - Digging deeper into oral anticoagulants
Topic: Drug therapy
Speaker: Mr M. Tarsillo (North Haven, US)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Mr Marc Tarsillo

Quinnipiac University , North Haven (United States of America)
0 follower

4 more presentations in this session

Anti-Xa concentration better than activated partial thromboplastin time for the monitoring of unfractionated heparin treatment.

Speaker: Assistant Professor T. Moumneh (Tours, FR)

Access
Abstract
Slides
Like
Thumbnail

Effects of factor Xa inhibitors rivaroxaban and apixaban on platelet function

Speaker: Associate Professor G. Renda (Chieti, IT)

Access
Abstract
Slides
Like
Thumbnail

Impact of hemorrhagic events during dual antiplatelet therapy after drug-eluting stent implantation in patients with hemodialysis

Speaker: Doctor A. Shimizu (Kitakyushu, JP)

Access
Abstract
Like
Thumbnail

Use of vitamin K antagonists in patients aged 85 years or over: analysis of thromboembolic and hemorrhagic events.

Speaker: Doctor D. Moreira (Sao Paulo, BR)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 2 - Digging deeper into oral anticoagulants

Speakers: Mr M. Tarsillo, Assistant Professor T. Moumneh, Associate Professor G. Renda, Doctor A. Shimizu, Doctor D. Moreira
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources